The Arizona Bioindustry Association ( AZBio ) today announced that Calimmune, Inc., acquired by CSL Limited in 2017, will be honored as the Arizona Bioscience Company of the Year by the state’s bioscience and business community at the 2018 AZBio Award on Oct. 3 at the Phoenix Convention Center. On a mission to cure the […]
Building on a long-standing commitment to foot comfort, Kentwool, maker of the “World’s Best Sock,” announced today the introduction of a therapeutic sock for foot pain relief. The new SensationWool sock features Kentwool’s signature, superfine Merino wool in combination with Nufabrx® nylon, which is infused with capsaicin and a synthetic cooling agent. This combination of […]
By Ali Parnian – Contributing writer I recently met with Gregg Scoresby, CEO of CampusLogic Inc., at his newly expanded headquarters in Chandler. A high-growth company that wants to “Help Schools Change Lives,” its software is geared toward helping higher education institutions and their students more easily handle student financial services. Read on for Scoresby’s […]
Cancer Prevention Pharmaceuticals, Inc. (CPP), a private biotech company developing novel therapeutics to prevent cancer and other diseases, announced the signing of a license agreement with Mallinckrodt Pharmaceuticals, through its Sucampo AG subsidiary (“Mallinckrodt”), wherein Mallinckrodt obtained exclusive North American commercialization rights to CPP’s lead drug candidate, CPP-1X/sul. In April 2018, UK-based Mallinckrodt had exercised […]
In 2006, former Vice President Al Gore came out of obscurity to share a message: the world is heating up. “An Inconvenient Truth” won an Academy Award and made climate change a household term. But what happened next may have done more harm than good for the clean energy startup space. In the months after the […]
Reglagene Holding, Inc. was selected as an Innovation Excellence winner of the Freedom from Cancer Startup Challenge (FCSC). The FCSC is a nationwide contest dedicated to startups that better prevent, diagnose, treat, and cure cancers. Winners of the Cancer Startup Challenge were selected by a multi-disciplinary judging panel, comprised of industry experts, potential investors, philanthropists, […]
Evan Unger, MD, President and CEO of NuvOx Pharma, announced that NuvOx has received a $2M Phase II Small Business Innovation Research (SBIR) grant from the National Cancer Institute to fund the development of a new strategy to detect pancreatic cancer. The grant, 2R44CA203090-02, entitled “Thy-1 targeted microbubbles for early detection of pancreatic cancer,” is […]
GammaTile Therapy is the Next Step in the Expansion of Cesium to Additional Markets IsoRay, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers and GT Medical Technologies, Inc., today announced the receipt of […]
Regulonix, LLC, a University of Arizona biotechnology start-up company focused on developing non-opioid therapeutics to relieve chronic pain, today announced seed investment of $2 million. UAVenture Capital Fund, LLC, the Tucson-based early stage capital fund dedicated to commercializing University of Arizona (UA) technology, led the seed round, with participation from Tucson’s Desert Angels, one of the country’s […]
Tucson-based startup Vector Launch has garnered some valuable brand awareness recently, but the time for talk is ending, CEO Jim Cantrell says. The media-savvy Cantrell has been popping up on TV and other media outlets to talk about the company as it works toward its goal of launching mini-satellites into orbit later this year. Cantrell […]